(Reuters) – Novavax Inc and partner Serum Institute of India said On Monday they received the emergency use authorization from Indonesia, making it the first authorization anywhere for Novavax.
The shot will be sold under Serum Institute’s brand name for the vaccine, Covovax.
(Reporting by Dania Nadeem in Bengaluru; Editing by Maju Samuel)
